Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Methods in Molecular Medicine|May 25, 2005
Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapyDavid E ModrakMolecular Cancer Therapeutics|March 1, 2006
Sphingolipid targets in cancer therapyDavid E Modrak, David V Gold, David M GoldenbergMolecular Cancer Research : MCR|June 18, 2009
Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell linesDavid E Modrak, Evelyn Leon, David M Goldenberg, et al.International Journal of Cancer|March 3, 2004
Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograftDavid V Gold, David E Modrak, Keith Schutsky, et al.International Journal of Oncology|January 15, 2002
Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenograftsDavid E Modrak, Marisol D Rodriguez, David M Goldenberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinomaDavid V Gold, Zarir Karanjawala, David E Modrak, et al.Cancer Research|November 19, 2004
Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancerDavid E Modrak, Thomas M Cardillo, Guy A Newsome, et al.International Journal of Oncology|May 5, 2005
Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16)David E Modrak, Habibe Karacay, Thomas M Cardillo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2005
New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitisDavid V Gold, David E Modrak, Zhiliang Ying, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2010
Detection of early-stage pancreatic adenocarcinomaDavid V Gold, Michael Goggins, David E Modrak, et al.Pageof 2